Skip to content
Cybersecurity ETF Gains Amid Rising Threats

Cybersecurity ETF Gains Amid Rising Threats

First seen 16 Oct 2026, 06:48 UTC • •
API

Article Content

Browse articles
ThreatCluster AI
ThreatCluster •October 16, 2026 at 09:38 UTC
  • •Amplify Cybersecurity ETF (HACK) trading at $130.76, up 4.32%.
  • •ETF gained 84.96% from its 52-week low, driven by rising cybersecurity threats.
  • •Short interest increased by 243.1% in September, indicating potential volatility.

The Amplify Cybersecurity ETF (HACK) has seen a significant increase in value, trading at $130.76, up 4.32% as of October 12, 2026. This rise is attributed to heightened concerns over cybersecurity threats, particularly related to AI safety. The ETF has gained 84.96% from its 52-week low of $69.66, reflecting strong demand in the cybersecurity sector. However, short interest surged by 243.1% in September, indicating potential volatility. Investors are advised to monitor sector earnings and AI-driven security spending trends. HACK provides diversified exposure to the global cybersecurity industry, with key holdings in major firms like Broadcom and Cisco. The ETF's performance contrasts with other stocks in the healthcare sector, such as Takeda Pharmaceutical and Spyre Therapeutics, which are not experiencing similar growth.

Start a free Starter trial for enhanced analysis

Ask AI about this cluster

Updated 1h ago How this analysis works

Timeline

2026-09-01
Short interest surged
Short interest in HACK increased by 243.1%, indicating potential volatility in the ETF's performance.
Pluang
2026-10-12
HACK hits new 52-week high
Amplify Cybersecurity ETF trades at $130.76, reflecting strong demand amid rising cybersecurity concerns.
Pluang

More articles in this cluster (2)

Extracted Entities

1 / 2

Common questions

What is driving the ETF's growth?
The growth is driven by increased concerns over cybersecurity threats, particularly related to AI.
How does HACK compare to other stocks?
HACK has significantly outperformed stocks like Takeda Pharmaceutical and Spyre Therapeutics in recent weeks.
What should investors watch for?
Investors should monitor sector earnings and AI-driven security spending trends for potential growth opportunities.